March Roundup of FDA Approvals in Oncology: 4 Decisions to Know OncLive In 2023, the FDA deemed 19 peptides too unsafe to be dispensed by compounding pharmacies. Now, under RFK Jr., the agency is poised to reverse itself despite the fact that few FDA Action Update, January 2026: Approvals, Acceptance, and Clearance NeurologyLive Clinical Neurology News and Neurology Expert Insights Peptides: FDA Approved vs Research Peptides Not all peptides are created equal Some are FDA approved medications with real clinical data, regulated manufacturing, and proven safety. Others are sold online as